CClinicalTrials.gg
CompletedNCT05183672Updated Sep 17, 2026

Improving Post-acute Stroke Follow-up Care by Adopting Telecare Consultations in a Nurse-led Clinic

An interventional study of Telecare consultation and Usual face-to-face consultation in Stroke, sponsored by The Hong Kong Polytechnic University. Completed at 1 site in Hong Kong. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-17.

Sponsored by The Hong Kong Polytechnic University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
196
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Since 2017, Hong Kong has provided post-acute stroke services in clinics operated by stroke advanced practice nurses (APNs). Currently, the applicability of the clinics has been further limited by the emergence of the coronavirus (COVID-19) pandemic due to restrictions on visits to the clinics and tightened social distancing requirements. Telecare consultations may be a viable option for contributing more flexible, interactive, and cost-efficient care models to support stroke survivors over the longer run. The present study takes advantage of this opportunity by utilizing implementation science to simultaneously implement and evaluate a telecare model of care in a nurse-led post-acute stroke clinic.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • stroke
  • telecare consultation
03

In context

Stroke

7,287 studies on the registry are indexed under Stroke; 2,006 are open to participants now.

This study's enrollment of 196 is above the median of 50 across 5,370 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

The Hong Kong Polytechnic University is the lead sponsor of 659 studies on the registry; 250 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • confirmed diagnosis of stroke within 1 month before enrolment, will be discharged home within a week, aged 18 or above, cognitively competent with a score equal to or greater than 22 in the Montreal Cognitive Assessment Hong Kong version, own a smartphone

Exclusion criteria

Exclusion Criteria:

  • have unaccompanied hearing or vision loss, cannot be reached by phone, bedbound, have no Internet connection at home, participating in other clinical trials at the same time, require physical contact, i.e. wound dressing
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
196 participants (actual)

Study arms

  • Experimental
    Intervention group

    Participants will receive three tertiary stroke care consultations provided by stroke nurses via telecare in 3 months.

    Procedure: Telecare consultation

  • Placebo comparator
    Control group

    Participants will receive three usual face-to-face consultations provided by stroke nurses in 3 months

    Procedure: Usual face-to-face consultation

Interventions

  • ProcedureTelecare consultation

    Using Zoom to communicate with patients

  • ProcedureUsual face-to-face consultation

    Face-to-face communication with patients

06

What researchers measure

Primary outcomes

  1. Chang in Degree of disability after stroke

    Simplified modified Rankin scale will be used to measure the degree of disability for stroke patients. The scale has three questions to identify whether the patient has a score from 0 to 5, with higher scores representing higher degree of disability.

    Time frame: baseline, three months when the program is completed, three months after the program is completed.

Secondary outcomes

  1. Incidence of the recurrence of stroke

    The percentage of participants who re-admitted to hospital because of recurrent stroke

    Time frame: baseline, three months when the program is completed, three months after the program is completed.

  2. Change of Quality of life, which measures an individual perception oftheir position in life. It includes physical and mental health.

    Quality of life will be measured using the Hong Kong version of EuroQol 5-dimension. The scale has five subdomains, which include mobility, self-care, usual activities, pain and discomfort, and anxiety and depression. Since the scale has 5 items, each digit in the five digit codes refers to the status of each dimension, ranging from 1 for no problem, to 5 for sever problem. A higher scores indicate better quality of life.

    Time frame: baseline, three months when the program is completed, three months after the program is completed.

  3. Change of Post-stroke depression

    Post-stroke depression will be measured using the Chinese version of the Geriatric Depression scale. This scale has a minimum score of 0 and a maximum score of 15. Lower scores represent lower depression level.

    Time frame: baseline, three months when the program is completed, three months after the program is completed.

  4. Change of Medication adherence

    Medication adherence will be determined using the Adherence to Refills and Medications Scale. The scale produces an overall adherence score of 10-40, with lower scores indicating better adherence.

    Time frame: baseline, three months when the program is completed, three months after the program is completed.

  5. Change of Social participation

    Social participation will be measured using the 11-item Reintegration to Normal Living index. This scale is used to measure whether the patient has participated in several social activities before and after occurrence of stroke. The scale yields total score from 0-22, with higher scores indicating poorer social participation.

    Time frame: baseline, three months when the program is completed, three months after the program is completed.

  6. Number of attendances at a general practitioners' office, emergency department, hospital, and general out-patient clinic

    To measure the utilization of healthcare services by stroke patient before and after the intervention

    Time frame: baseline, three months when the program is completed, three months after the program is completed.

Other outcomes

  1. Cost effectiveness of the program

    Cost and quality-adjusted life years will be collected at baseline, three months when the program is completed, and three months after the program is completed. Incremental cost-effectiveness ratios between the groups will be calculated by dividing the difference in cost by the difference in quality-adjusted life years.

    Time frame: baseline, three months when the program is completed, three months after the program is completed.

07

Study locations

1 site
  • Queen Elizabeth Hospital
    Kowloon, Hong Kong
08

References and documents

Publications

  • Wong AKC, Kwok VWY, Wong FKY, Tong DWK, Yuen BMK, Fong CS, Chan ST, Li WC, Zhou S, Lee AYL. Improving post-acute stroke follow-up care by adopting telecare consultations in a nurse-led clinic: Study protocol of a hybrid implementation-effectiveness trial. J Adv Nurs. 2024 Mar;80(3):1222-1231. doi: 10.1111/jan.15960. Epub 2023 Nov 10. PubMed 37950400 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05183672
Lead sponsor
The Hong Kong Polytechnic University
Collaborators
The Queen Elizabeth Hospital
Responsible party
Arkers, Wong (Assistant professor, The Hong Kong Polytechnic University) — Principal investigator
First posted
Jan 10, 2022
Start date
Dec 1, 2022
Primary completion
Oct 30, 2025
Completion
Dec 30, 2025
Last update
Sep 17, 2026

Study contacts

Arkers Wong, Ph.D.
principal investigator · The Hong Kong Polytechnic University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion